ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical r&d expenses
Research and development expenses are spending on new products and technology.
ENvue Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.24M, down 42.3% year over year. For fiscal 2025 it was $1.76M, up 93.8% from the year before. Over ten years it grew 16.0% a year on average. The highest annual figure on record is $1.76M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76M | +93.8% |
| FY2024 | Dec 31, 2024 | $909.00K | +391.4% |
| FY2023 | Dec 31, 2023 | $185.00K | -34.6% |
| FY2022 | Dec 31, 2022 | $283.00K | -3.4% |
| FY2021 | Dec 31, 2021 | $293.00K | +71.3% |
| FY2020 | Dec 31, 2020 | $171.00K | -66.7% |
| FY2019 | Dec 31, 2019 | $514.00K | -16.3% |
| FY2018 | Dec 31, 2018 | $614.00K | -11.4% |
| FY2017 | Dec 31, 2017 | $693.00K | +18.7% |
| FY2016 | Dec 31, 2016 | $584.00K | +46.4% |
| FY2015 | Dec 31, 2015 | $399.00K | -7.4% |
| FY2014 | Dec 31, 2014 | $431.00K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $510.00K | -49.8% |
| Q1 FY2026 | Mar 31, 2026 | $468.00K | -11.7% |
| Q4 FY2025 | Dec 31, 2025 | $39.00K | -88.9% |
| Q3 FY2025 | Sep 30, 2025 | $221.00K | -11.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.02M | +443.3% |
| Q1 FY2025 | Mar 31, 2025 | $530.00K | +338.0% |
| Q4 FY2024 | Dec 31, 2024 | $352.00K | +467.7% |
| Q3 FY2024 | Sep 30, 2024 | $249.00K | +654.5% |
| Q2 FY2024 | Jun 30, 2024 | $187.00K | +434.3% |
| Q1 FY2024 | Mar 31, 2024 | $121.00K | +120.0% |
| Q4 FY2023 | Dec 31, 2023 | $62.00K | -42.1% |
| Q3 FY2023 | Sep 30, 2023 | $33.00K | -32.7% |
| Q2 FY2023 | Jun 30, 2023 | $35.00K | -42.6% |
| Q1 FY2023 | Mar 31, 2023 | $55.00K | -16.7% |
| Q4 FY2022 | Dec 31, 2022 | $107.00K | -7.0% |
| Q3 FY2022 | Sep 30, 2022 | $49.00K | -2.0% |
| Q2 FY2022 | Jun 30, 2022 | $61.00K | -4.7% |
| Q1 FY2022 | Mar 31, 2022 | $66.00K | +3.1% |
| Q4 FY2021 | Dec 31, 2021 | $115.00K | +187.5% |
| Q3 FY2021 | Sep 30, 2021 | $50.00K | -26.5% |
| Q2 FY2021 | Jun 30, 2021 | $64.00K | +300.0% |
| Q1 FY2021 | Mar 31, 2021 | $64.00K | +36.2% |
| Q4 FY2020 | Dec 31, 2020 | $40.00K | -69.9% |
| Q3 FY2020 | Sep 30, 2020 | $68.00K | -13.9% |
| Q2 FY2020 | Jun 30, 2020 | $16.00K | -89.3% |
| Q1 FY2020 | Mar 31, 2020 | $47.00K | -69.1% |
| Q4 FY2019 | Dec 31, 2019 | $133.00K | -35.4% |
| Q3 FY2019 | Sep 30, 2019 | $79.00K | -34.7% |
| Q2 FY2019 | Jun 30, 2019 | $150.00K | -0.7% |
| Q1 FY2019 | Mar 31, 2019 | $152.00K | +11.8% |
| Q4 FY2018 | Dec 31, 2018 | $206.00K | -5.9% |
| Q3 FY2018 | Sep 30, 2018 | $121.00K | -24.4% |
| Q2 FY2018 | Jun 30, 2018 | $151.00K | -7.9% |
| Q1 FY2018 | Mar 31, 2018 | $136.00K | -9.3% |
| Q4 FY2017 | Dec 31, 2017 | $219.00K | +26.6% |
| Q3 FY2017 | Sep 30, 2017 | $160.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $164.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $150.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $173.00K | – |
See a number that looks wrong?